Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Cancer Discov. 2016 Jul 17;6(9):1052–1067. doi: 10.1158/2159-8290.CD-15-1227

Table 2.

New cross-cancer loci identified at P < 10−8 that were over 1 Mb away from known index SNPs

Region, positiona Index SNP, (n), nearest gene Alleles (E/R), EAF Cancer Type OR (95% CI) P ASSET model, Phetb r2c
A: From the three-cancer meta-analysis
Associations with breast, ovarian and prostate cancer risk with the same direction of effect
2q13 rs17041869 A/G Breast cancer 0.97 (0.94–0.99) 7.1×10−3 3-cancer 1d
111896243 (3) 0.88 Ovarian cancer 0.93 (0.88–0.97) 5.3×10−4 0.07 1d
BCL2L11 Prostate cancer 0.92 (0.89–0.95) 2.6×10−6 1d
Meta-analysis 0.94 (0.93–0.96) 5.1×10−9
11q12 rs7937840 T/C Breast cancer 1.04 (1.02–1.06) 3.6×10−5 3-cancer 0.89
61893972 (1) 0.26 Ovarian cancer 1.05 (1.01–1.09) 5.8×10−3 0.95 0.90
INCENP Prostate cancer 1.05 (1.02–1.08) 8.9×10−4 0.89
Meta-analysis 1.05 (1.03–1.06) 5.0×10−9
19p13 rs1469713 A/G Breast cancer 0.95 (0.94–0.97) 9.9×10−8 3-cancer 0.98
19528806 (89) 0.64 Ovarian cancer 0.96 (0.93–0.99) 6.3×10−3 0.64 0.98
GATAD2A Prostate cancer 0.97 (0.94–0.99) 1.0×10−2 0.95
Meta-analysis 0.96 (0.95–0.97) 3.4×10−10
B: From the pairwise meta-analyses
Associations with breast and ovarian cancer risk with the same direction of effect
9q31 rs200182588 G/GGC Breast cancer 0.96 (0.94–0.98) 1.9×10−5 2-cancer 0.81
106856690 (15) 0.56 Ovarian cancer 0.93 (0.89–0.96) 2.8×10−6 0.08 0.82
SMC2 Meta-analysis 0.95 (0.94–0.97) 8.9×10−9
15q26 rs8037137 T/C Breast cancer 1.07 (1.04–1.10) 1.8×10−7 2-cancer 0.98
91506637 (33) 0.86 Ovarian cancer 1.09 (1.04–1.14) 2.1×10−4 0.58 0.98
RCCD1 Meta-analysis 1.07 (1.05–1.10) 9.1×10−10
Associations with breast and prostate cancer risk with the same direction of effect
1p34 rs5013329 T/C Breast cancer 1.04 (1.02–1.06) 7.8×10−6 2-cancer 0.98
46815091 (218) 0.31 Prostate cancer 1.07 (1.04–1.10) 1.4×10−7 0.09 0.98
NSUN4 Meta-analysis 1.05 (1.04–1.07) 1.8×10−11
6q23 rs9375701 T/C Breast cancer 1.04 (1.02–1.06) 3.6×10−6 2-cancer 0.99
130384057 (53) 0.67 Prostate cancer 1.06 (1.03–1.08) 1.5×10−5 0.41 0.99
L3MBTL3 Meta-analysis 1.05 (1.03–1.06) 3.4×10−10

Abbreviations: n, Number of SNPs with P < 10−8 within 1 Mb of the index SNP; (E/R), (effect/reference) alleles; EAF: effect allele frequency.

a

Build 37 coordinates.

b

Cochran’s Q-test for heterogeneity P-value.

c

Imputation accuracy, r2, in iCOGS European samples.

d

Genotyped SNP.